QILU PHARMACEUTICAL
Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilarCipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...
need2know: 10 market-moving macro triggers to watch todayA lowdown on top macro triggers that are likely to move the market on Monday
- Load More